
Phu Hoang Nguyen
Examiner (ID: 14741, Phone: (571)272-5931 , Office: P/1747 )
| Most Active Art Unit | 1747 |
| Art Unit(s) | 1731, 1747, 1791 |
| Total Applications | 942 |
| Issued Applications | 511 |
| Pending Applications | 112 |
| Abandoned Applications | 343 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12975469
[patent_doc_number] => 20170340572
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-30
[patent_title] => STABILIZATION OF BETA-HYDROXYISOVALERIC ACID FORMULATIONS IN SOFT GEL CAPSULES
[patent_app_type] => utility
[patent_app_number] => 15/605664
[patent_app_country] => US
[patent_app_date] => 2017-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3523
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15605664
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/605664 | Stabilization of beta-hydroxyisovaleric acid formulations in soft gel capsules | May 24, 2017 | Issued |
Array
(
[id] => 12029517
[patent_doc_number] => 20170319617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-09
[patent_title] => 'COMPOSITION FOR THE TREATMENT OF DISEASE'
[patent_app_type] => utility
[patent_app_number] => 15/598819
[patent_app_country] => US
[patent_app_date] => 2017-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 18202
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15598819
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/598819 | COMPOSITION FOR THE TREATMENT OF DISEASE | May 17, 2017 | Abandoned |
Array
(
[id] => 14609561
[patent_doc_number] => 10357458
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-23
[patent_title] => Liposomal mitigation of drug-induced long QT syndrome and potassium delayed-rectifier current
[patent_app_type] => utility
[patent_app_number] => 15/597411
[patent_app_country] => US
[patent_app_date] => 2017-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 17
[patent_no_of_words] => 12574
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 185
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15597411
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/597411 | Liposomal mitigation of drug-induced long QT syndrome and potassium delayed-rectifier current | May 16, 2017 | Issued |
Array
(
[id] => 14682033
[patent_doc_number] => 20190240131
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-08
[patent_title] => AQUEOUS SURFACTANT COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/317132
[patent_app_country] => US
[patent_app_date] => 2017-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3290
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 316
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16317132
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/317132 | AQUEOUS SURFACTANT COMPOSITIONS | May 10, 2017 | Abandoned |
Array
(
[id] => 16589252
[patent_doc_number] => 10898494
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-26
[patent_title] => Dry powder treprostinil for the treatment of pulmonary hypertension
[patent_app_type] => utility
[patent_app_number] => 16/099135
[patent_app_country] => US
[patent_app_date] => 2017-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 29310
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16099135
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/099135 | Dry powder treprostinil for the treatment of pulmonary hypertension | May 4, 2017 | Issued |
Array
(
[id] => 11864605
[patent_doc_number] => 20170231889
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-17
[patent_title] => 'Sunscreen Compositions Comprising Colour Pigments'
[patent_app_type] => utility
[patent_app_number] => 15/586818
[patent_app_country] => US
[patent_app_date] => 2017-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13878
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15586818
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/586818 | Sunscreen Compositions Comprising Colour Pigments | May 3, 2017 | Abandoned |
Array
(
[id] => 14960425
[patent_doc_number] => 20190307690
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-10
[patent_title] => Liposomal Delivery Systems for Oxaliplatin and in Dual Drug Delivery in Combination with Chemo-sensitizing and Chemo-therapeutic agents
[patent_app_type] => utility
[patent_app_number] => 16/098509
[patent_app_country] => US
[patent_app_date] => 2017-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7655
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16098509
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/098509 | Liposomal Delivery Systems for Oxaliplatin and in Dual Drug Delivery in Combination with Chemo-sensitizing and Chemo-therapeutic agents | May 1, 2017 | Abandoned |
Array
(
[id] => 16876677
[patent_doc_number] => 11026794
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-08
[patent_title] => Reinforced bone scaffold
[patent_app_type] => utility
[patent_app_number] => 16/092672
[patent_app_country] => US
[patent_app_date] => 2017-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 12
[patent_no_of_words] => 6918
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16092672
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/092672 | Reinforced bone scaffold | May 1, 2017 | Issued |
Array
(
[id] => 17937126
[patent_doc_number] => 11471558
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-18
[patent_title] => Polypeptide and hyaluronic acid coatings
[patent_app_type] => utility
[patent_app_number] => 16/098372
[patent_app_country] => US
[patent_app_date] => 2017-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 34
[patent_no_of_words] => 20063
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16098372
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/098372 | Polypeptide and hyaluronic acid coatings | May 1, 2017 | Issued |
Array
(
[id] => 14182533
[patent_doc_number] => 20190110971
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-18
[patent_title] => COMPOSITIONS FOR MANAGING PLAQUE FORMATION
[patent_app_type] => utility
[patent_app_number] => 16/097128
[patent_app_country] => US
[patent_app_date] => 2017-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8446
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -135
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16097128
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/097128 | COMPOSITIONS FOR MANAGING PLAQUE FORMATION | Apr 27, 2017 | Abandoned |
Array
(
[id] => 16861653
[patent_doc_number] => 11020375
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-01
[patent_title] => Edaravone dosage form
[patent_app_type] => utility
[patent_app_number] => 16/084668
[patent_app_country] => US
[patent_app_date] => 2017-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 7937
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16084668
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/084668 | Edaravone dosage form | Apr 20, 2017 | Issued |
Array
(
[id] => 14273293
[patent_doc_number] => 20190133931
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-09
[patent_title] => SUBCONJUNCTIVAL DEPOT FORMING FORMULATIONS FOR OCULAR DRUG DELIVERY
[patent_app_type] => utility
[patent_app_number] => 16/095269
[patent_app_country] => US
[patent_app_date] => 2017-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7277
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16095269
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/095269 | SUBCONJUNCTIVAL DEPOT FORMING FORMULATIONS FOR OCULAR DRUG DELIVERY | Apr 18, 2017 | Abandoned |
Array
(
[id] => 16532042
[patent_doc_number] => 10874617
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-29
[patent_title] => Oral pharmaceutical compositions of mesalazine
[patent_app_type] => utility
[patent_app_number] => 16/094644
[patent_app_country] => US
[patent_app_date] => 2017-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 13
[patent_no_of_words] => 10054
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 160
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16094644
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/094644 | Oral pharmaceutical compositions of mesalazine | Apr 17, 2017 | Issued |
Array
(
[id] => 14156351
[patent_doc_number] => 20190105278
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-11
[patent_title] => SHELLAC MICROCAPSULE FORMULATIONS AND COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/094656
[patent_app_country] => US
[patent_app_date] => 2017-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13272
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16094656
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/094656 | SHELLAC MICROCAPSULE FORMULATIONS AND COMPOSITIONS | Apr 11, 2017 | Abandoned |
Array
(
[id] => 12562437
[patent_doc_number] => 10016380
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-10
[patent_title] => Antimicrobials and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 15/484827
[patent_app_country] => US
[patent_app_date] => 2017-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 49
[patent_no_of_words] => 23508
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15484827
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/484827 | Antimicrobials and methods of use thereof | Apr 10, 2017 | Issued |
Array
(
[id] => 17755530
[patent_doc_number] => 11395808
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-26
[patent_title] => Delayed release pharmaceutical formulations comprising valproic acid, and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/090664
[patent_app_country] => US
[patent_app_date] => 2017-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 33993
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16090664
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/090664 | Delayed release pharmaceutical formulations comprising valproic acid, and uses thereof | Apr 9, 2017 | Issued |
Array
(
[id] => 14227501
[patent_doc_number] => 20190125923
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-02
[patent_title] => JELLYFISH EXTRACT NANOFIBERS
[patent_app_type] => utility
[patent_app_number] => 16/092546
[patent_app_country] => US
[patent_app_date] => 2017-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10678
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16092546
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/092546 | JELLYFISH EXTRACT NANOFIBERS | Apr 9, 2017 | Abandoned |
Array
(
[id] => 14227221
[patent_doc_number] => 20190125783
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-02
[patent_title] => AGENT FOR USE FOR INFLAMMATORY CONDITIONS OF MUCOUS MEMBRANES
[patent_app_type] => utility
[patent_app_number] => 16/091823
[patent_app_country] => US
[patent_app_date] => 2017-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4464
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16091823
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/091823 | Agent for use for inflammatory conditions of mucous membranes | Apr 6, 2017 | Issued |
Array
(
[id] => 14338531
[patent_doc_number] => 20190151238
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-23
[patent_title] => TREATMENT OF INFLAMMATORY BOWEL DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/091312
[patent_app_country] => US
[patent_app_date] => 2017-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6685
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16091312
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/091312 | Treatment of inflammatory bowel disease | Apr 5, 2017 | Issued |
Array
(
[id] => 14182549
[patent_doc_number] => 20190110979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-18
[patent_title] => PERSONAL CARE COMPOSITIONS AND METHODS FOR USING SUCH COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/091212
[patent_app_country] => US
[patent_app_date] => 2017-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15308
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16091212
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/091212 | PERSONAL CARE COMPOSITIONS AND METHODS FOR USING SUCH COMPOSITIONS | Apr 4, 2017 | Pending |